Skip to main content

EDITORIAL article

Front. Physiol., 12 April 2023
Sec. Renal Physiology and Pathophysiology
This article is part of the Research Topic Peritoneal Dialysis: Recent Advances and State of the Art View all 24 articles

Editorial: Peritoneal dialysis: Recent advances and state of the art

  • 1Fresenius Medical Care, Global Medical Office, Waltham, MA, United States
  • 2Botucatu Medical School, São Paulo State University, Universidade do Estado de São Paulo, Botucatu, São Paulo, Brazil
  • 3Post Graduate Program in Health and Biological Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil

Introduction

Peritoneal dialysis (PD) is a widely used treatment for patients with kidney failure/end-stage kidney disease, and a suitable alternative to hemodialysis (HD). Existing for over 40 years (BOEN, 1961), the adoption of PD has varied widely across the world for different reasons (Struijk, 2015; Pecoits-Filho et al., 2020; United States Renal Data System, 2022). The Global Kidney Health Atlas reports that, on average, 38.1 per million population (pmp) of people receive chronic PD treatment, which is considerably lower than the estimated global prevalence of HD, which is 298.4 pmp (Bello et al., 2019).

PD has several advantages over HD, including better preservation of residual kidney function, better blood pressure control, and a more flexible and independent treatment schedule that provides greater patient autonomy (Sinnakirouchenan and Holley, 2011; Francois and Bargman, 2014; Brown et al., 2020). PD can also have lower costs for patients and the healthcare system, making it an attractive option for some patients and providers. Despite the potential benefits of PD, there are also challenges associated with the modality including fluid control and solute removal, among other factors (Sinnakirouchenan and Holley, 2011; Brown et al., 2020). This Research Topic highlights 22 contributions from experts who explored several of these challenges and brought new insights learned across four continents. The topic of the contributions varied within this Research Topic (Figure 1), demonstrating the many areas in which improvements and advancements are needed in the delivery of PD and care of patients using the modality. Although we continue to lack important information in the field, these contributions bring a better understanding of the therapy. We invite you to read and enjoy all of them.

FIGURE 1
www.frontiersin.org

FIGURE 1. Distribution of PD themes within the Research Topic.

Featured publications

Some topics were more common in this Research Topic, and we’d like to highlight them here. The leading theme was related to problems with catheter insertion, which accounted for almost one out of every four papers published in this Research Topic. PD catheter insertion is a mandatory step in initiating and maintaining chronic PD, and the rates of catheter dysfunction can reach upward to 30% (Szeto et al., 2017). Given this, catheter insertion is always arousing great interest in the PD community. Of these five manuscripts directly related to catheter insertion, two explored different implantation techniques (Jakšić et al.; Yamashita et.), and three evaluated risk factors for catheter failure Chang et al.; Zhao et al.; Hangai et al. Two of these manuscripts add an interesting discussion to the literature about the impact of unplanned PD on outcomes Zhao et al.; Hangai et al.

In second comes manuscripts involving nutrition, totalling four articles Do et al.; Roth-Stefanski et al.; Verger et al.; Guedes et al. Nutrition is a critical aspect of care for patients on PD, as it can affect both short-term and long-term outcomes. These manuscripts shed light on several important aspects related to nutrition in PD including the risk factors for sarcopenia, the diagnosis of protein-energy-wasting, impact of PD prescription on body composition, and an interesting discussion involving inflammation, nutrition, and protein loss.

Other themes included three papers that explored ways to try to optimize ultrafiltration and prevent volume overload in PD (Maggiani-Aguilera et al.; Song et al.; Zhang et al.), two papers that investigated ways to improve detection and prevention cardiovascular disease in the PD population (Kharche et al.; Xia et al.), as well as two papers that investigated risk factors for peritonitis and associated technique failure events (He et al.; Li et al.). Finally, but not less important, other articles of this series investigated associations in CKD-MBD biomarkers and survival (Huang et al.), the use of PD for patients with chronic liver failure and acute kidney injury (Ponce et al.), periodontal disease and alveolar bone loss in PD (Sun et al.), a method to increase physical activity and quality of life in a controlled trial (Zhang et al.), and a review detailing the pathophysiology of peritoneal membrane aging (Krediet).

Summary

In summary, all the excellent articles published in this Research Topic reinforce the huge variety of needs in the provision care in PD patients, advancements by the scientific community, and the numerous research opportunities to be addressed within the field of PD. Ongoing efforts are needed to improve the quality of care for patients on PD and to increase the availability and utilization of the modality worldwide.

Author contributions

All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.

Conflict of interest

Author JL reports being an employee of Fresenius Medical Care, having share options/ownership in Fresenius Medical Care, being an inventor on patent(s) in the field of dialysis, and receipt of honorarium from The Lancet. Author PB reports receipt of speaker honorarium and consultant fees from Baxter. Author TPM reports receipt of speaker honorarium and consultant fees from Baxter, Boehringer, Lilly, Bayer & Astrazeneca, and scholarships from the Brazilian Council for Research (CNPq).

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Bello, A., Levin, A., Lunney, M., Osman, M., Ye, F., Ashuntantang, G., et al. (2019). Global kidney Health Atlas: A report by the international society of Nephrology on the global burden of end-stage kidney disease and capacity for kidney replacement therapy and conservative care across world countries and regions. Brussels: International Society of Nephrology.

Google Scholar

Boen, S. T. (1961). Kinetics of peritoneal dialysis: A comparison with the artificial kidney. Medicine 40, 243–288. doi:10.1097/00005792-196109000-00001

CrossRef Full Text | Google Scholar

Brown, E. A., Blake, P. G., Boudville, N., Davies, S., De Arteaga, J., Dong, J., et al. (2020). International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis. Perit. Dial. Int. 40, 244–253. doi:10.1177/0896860819895364

PubMed Abstract | CrossRef Full Text | Google Scholar

Francois, K., and Bargman, J. M. (2014). Evaluating the benefits of home-based peritoneal dialysis. Int. J. Nephrol. Renov. Dis. 7, 447–455. doi:10.2147/IJNRD.S50527

PubMed Abstract | CrossRef Full Text | Google Scholar

Pecoits-Filho, R., Okpechi, I. G., Donner, J. A., Harris, D. C. H., Aljubori, H. M., Bello, A. K., et al. (2020). Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes. Kidney Int. Suppl. (2011) 10, e3–e9. doi:10.1016/j.kisu.2019.11.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Sinnakirouchenan, R., and Holley, J. L. (2011). Peritoneal dialysis versus hemodialysis: Risks, benefits, and access issues. Adv. Chronic Kidney Dis. 18, 428–432. doi:10.1053/j.ackd.2011.09.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Struijk, D. G. (2015). Peritoneal dialysis in western countries. Kidney Dis. (Basel) 1, 157–164. doi:10.1159/000437286

PubMed Abstract | CrossRef Full Text | Google Scholar

Szeto, C. C., Li, P. K., Johnson, D. W., Bernardini, J., Dong, J., Figueiredo, A. E., et al. (2017). ISPD catheter-related infection recommendations: 2017 update. Perit. Dial. Int. 37, 141–154. doi:10.3747/pdi.2016.00120

PubMed Abstract | CrossRef Full Text | Google Scholar

United States Renal Data System (2022). “2022 USRDS annual Data report: Epidemiology of kidney disease in the United States,” in National institutes of Health, national institute of diabetes and digestive and kidney diseases, bethesda, MD. United States Renal Data System (2022).

Google Scholar

Keywords: peritonitis, cardiovasclar disease, peritoneal membrane, technique failure, catheter insertion, nutrition, fluid overload

Citation: Larkin J, Barretti P and de Moraes TP (2023) Editorial: Peritoneal dialysis: Recent advances and state of the art. Front. Physiol. 14:1185810. doi: 10.3389/fphys.2023.1185810

Received: 14 March 2023; Accepted: 24 March 2023;
Published: 12 April 2023.

Edited and reviewed by:

Carolyn Mary Ecelbarger, Georgetown University, United States

Copyright © 2023 Larkin, Barretti and de Moraes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: John Larkin, am9obi5sYXJraW5AZnJlc2VuaXVzbWVkaWNhbGNhcmUuY29t; Pasqual Barretti, cGFzcXVhbC5iYXJyZXR0aUB1bmVzcC5icg==; Thyago Proença de Moraes, dGh5YWdvLm1vcmFlc0BwdWNwci5icg==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.